You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 30, 2026

Suppliers and packagers for LIGNOSPAN STANDARD


✉ Email this page to a colleague

« Back to Dashboard


LIGNOSPAN STANDARD

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390 ANDA Septodont, Inc. 0362-0898-05 50 CARTRIDGE in 1 CARTON (0362-0898-05) / 1.7 mL in 1 CARTRIDGE 2018-07-18
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390 ANDA Septodont, Inc. 0362-1095-60 5 BLISTER PACK in 1 CARTON (0362-1095-60) / 10 CARTRIDGE in 1 BLISTER PACK / 1.7 mL in 1 CARTRIDGE 2017-11-28
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390 ANDA Henry Schein Inc. 0404-6512-05 50 CARTRIDGE in 1 CARTON (0404-6512-05) / 1.7 mL in 1 CARTRIDGE 2011-11-07
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390 ANDA IQ Dental 42756-1030-5 50 CARTRIDGE in 1 CARTON (42756-1030-5) / 1.7 mL in 1 CARTRIDGE 2011-11-07
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390 ANDA NDC, Inc. 43128-105-15 50 CARTRIDGE in 1 CARTON (43128-105-15) / 1.7 mL in 1 CARTRIDGE 2015-04-10
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390 ANDA Patterson Dental 50227-1030-5 50 CARTRIDGE in 1 CARTON (50227-1030-5) / 1.7 mL in 1 CARTRIDGE 2011-11-07
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: LIGNOSPAN STANDARD

Last updated: August 3, 2025

Introduction

LIGNOSPAN STANDARD is a pharmaceutical compound primarily used as a lignosulfonate-based excipient or binder in pharmaceutical formulations. Its applications span tablet manufacturing, controlled-release formulations, and other pharmaceutical processes that require natural-origin excipients with binding, disintegrating, or stabilizing properties. As a specialized pharmaceutical ingredient, sourcing reputable suppliers for LIGNOSPAN STANDARD is crucial for ensuring product quality, regulatory compliance, and consistent supply chains.

This article provides a comprehensive overview of the key suppliers of LIGNOSPAN STANDARD, analyzing their production capabilities, regulatory compliance, and market positioning to inform pharmaceutical developers and procurement professionals.

Understanding LIGNOSPAN STANDARD

LIGNOSPAN STANDARD is derived from lignin, a natural biopolymer obtained as a byproduct in paper manufacturing. It undergoes sulfonation to improve solubility and functionality for pharmaceutical use. As a versatile excipient, its properties include binding capacity, disintegrating ability, and moisture retention. Regulatory agencies, particularly the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), recognize lignosulfonates for certain pharmaceutical applications, provided they meet specified purity and safety standards.

Leading Suppliers of LIGNOSPAN STANDARD

1. Borregaard AS

Overview:
Borregaard, a Norwegian biochemicals company, is a prominent producer of lignosulfonates, including LIGNOSPAN STANDARD. Their products are well-known for high purity, consistent quality, and sustainability. Borregaard operates a lignin-based product line derived from sustainably managed wood sources.

Capabilities:

  • Extensive R&D in lignosulfonate applications.
  • Global distribution network, ensuring supply continuity across major markets.
  • Compliance with pharmacopeial standards, including USP and EP.

Regulatory Compliance:
Borregaard’s LIGNOSPAN products are certified for pharmaceutical use, adhering to API purity specifications and free from heavy metals, residual solvents, or additives that could impact safety.

Market Position:
As a leader with integrated bio-refining processes, Borregaard’s reputation for environmentally sustainable practices makes it a preferred supplier among pharmaceutical manufacturers prioritizing green excipients.

2. Tembec Inc. (Now Part of Rayonier Advanced Materials)

Overview:
Tembec, acquired by Rayonier Advanced Materials, specializes in lignin-based products, including lignosulfonates suitable for pharmaceutical applications. Their proprietary processes optimize the purity and functionality of lignosulfonates.

Capabilities:

  • Ability to supply customized grades of lignosulfonates, including pharmaceutical-standard grades.
  • Vertical integration securing raw material sourcing and quality control.
  • Extensive experience in pharmaceutical and food industry compliance.

Compliance & Certification:
Tembec’s lignosulfonates for pharmaceutical use meet USP and EP standards, with clear documentation of traceability and safety profiles.

Market Position:
Their focus on high-purity grades and adaptable formulations makes them a competitive choice for formulators seeking reliable bulk supplies.

3. MeadWestvaco (Now part of WestRock)

Overview:
WestRock’s historical operations included the production of lignosulfonate-based biochemicals for industrial and pharmaceutical use. While their focus shifted over time, their legacy lignosulfonate products remain influential.

Capabilities:

  • High-volume manufacturing with rigorous quality assurance.
  • Focused on sustainable sourcing aligned with environmentally friendly manufacturing.

Regulatory Standing:
WestRock’s products conform to pharma-grade standards, with comprehensive documentation supportive of regulatory submissions.

4. Solvay SA

Overview:
Solvay, a global chemical powerhouse, produces specialty chemicals including lignosulfonates suitable for pharmaceutical and technical applications. Their lignosulfonates are known for high quality and consistency.

Capabilities:

  • Extensive R&D supporting custom modifications and functional enhancements.
  • Strong distribution channels worldwide.

Compliance:
Solvay’s lignosulfonates adhere to international pharmaceutical standards, with detailed analytical data supporting purity and safety.

Market Position:
Their reputation for innovative, high-performance excipients makes Solvay a strategic supplier for pharmaceutical firms.

5. Saba Ligno System Pvt Ltd. (India)

Overview:
Saba Ligno specializes in lignosulfonate products tailored for pharmaceutical use, especially in emerging markets. Their range includes various grades compatible with regulatory requirements.

Capabilities:

  • Competitive pricing and flexible batch sizes.
  • Commitment to quality control and customer-specific grades.

Regulatory & Certification:
Saba Ligno’s products are certified according to Indian Pharmacopoeia (IP) standards and aligned with international requirements.

Market Position:
An attractive choice for pharmaceutical manufacturers seeking cost-effective supplies without compromising compliance.

Considerations in Supplier Selection

When sourcing LIGNOSPAN STANDARD, key factors include:

  • Regulatory Compliance: Suppliers must provide Certificates of Analysis (CoA) confirming adherence to pharmacopeial standards (USP, EP, IP).
  • Quality Consistency: Ability to supply batches with minimal variance, critical for reproducibility in pharmaceutical formulations.
  • Supply Chain Reliability: Consider suppliers with global logistics capabilities to prevent shortages.
  • Sustainability and Transparency: Preference for companies with transparent sourcing and environmentally sustainable practices.
  • Customization Flexibility: In cases requiring specific grades or functional modifications, select suppliers with R&D support.

Global Market Overview

The market for lignosulfonates in pharmaceuticals is driven by increasing demand for natural excipients and regulatory shifts favoring sustainable ingredients. The Asia-Pacific region, particularly India and China, presents growing opportunities, with suppliers like Saba Ligno offering localized sourcing options. Mature markets in North America and Europe favor suppliers like Borregaard and Solvay, emphasizing regulatory compliance and environmental sustainability.

Conclusion

Securing a reliable source of LIGNOSPAN STANDARD involves evaluating suppliers on quality, regulatory adherence, supply stability, and sustainability. Global industry leaders such as Borregaard and Tembec (Rayonier Advanced Materials) stand out due to their rigorous standards and extensive experience. Emerging suppliers can offer cost efficiencies but must demonstrate compliance and consistent quality to meet pharmaceutical requirements.


Key Takeaways

  • Priority on Regulatory Compliance: Ensure suppliers provide comprehensive documentation aligning with pharmacopeial standards (USP, EP, IP).
  • Evaluate Quality Assurance Protocols: Consistent batch quality is crucial for formulation stability and regulatory approval.
  • Assess Supply Chain Resilience: Establish relationships with suppliers capable of meeting global demand without delays.
  • Consider Sustainability: Partner with companies committed to environmentally conscious sourcing, aligning with industry trends.
  • Leverage R&D Capabilities: Customized formulations and grades are often essential for specialized pharmaceutical applications.

FAQs

  1. Can I use lignosulfonates like LIGNOSPAN STANDARD in all pharmaceutical formulations?
    LIGNOSPAN STANDARD is suitable for various applications such as binders, disintegrants, and stabilizers, but suitability depends on specific formulation requirements and regulatory approval.

  2. What regulatory approvals are necessary for using LIGNOSPAN STANDARD in pharmaceuticals?
    Suppliers should certify that their products conform to pharmacopeial standards (USP, EP, IP) and provide documentation supporting safety and purity.

  3. How do I verify the quality of lignosulfonate suppliers?
    Request Certificates of Analysis, conduct audits, and review compliance history. Preference should be given to suppliers with GMP-certified manufacturing processes.

  4. Are there regional suppliers for LIGNOSPAN STANDARD?
    Yes, regional players like Saba Ligno in India serve local markets, often offering competitive pricing and shorter lead times, while global suppliers maintain extensive distribution networks.

  5. What are key factors influencing the choice of a supplier for LIGNOSPAN STANDARD?
    Regulatory compliance, quality consistency, supply capacity, sustainability practices, and ability to customize grades are critical criteria.


References

[1] U.S. Pharmacopeia (USP). "Lignosulfonates Monograph." 2022.
[2] European Pharmacopoeia (EP). "Lignosulfonates for Pharmaceutical Use." 2022.
[3] Borregaard official website: https://borregaard.com/
[4] Rayonier Advanced Materials: https://www.rayonier.com/
[5] Solvay SA: https://www.solvay.com/
[6] Saba Ligno System Pvt Ltd: https://sabaligno.com/

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.